Skip to main content
. 2014 Jul 17;5(7):e1346. doi: 10.1038/cddis.2014.302

Figure 1.

Figure 1

FZD7 expression was enriched in the Mes and Stem-A subtypes of ovarian cancer. (a) FZD7 gene expression data from 1538 ovarian tumour samples grouped into five, biologically distinct subgroups: Epi-A, Epi-B, Mes, Stem-A and Stem-B. (b) FZD7 transcript expression profile of patient tumour samples (JPKO collection) were assigned to the five subgroups. (c) FZD7 transcript expression levels in a panel of teratocarcinoma and OC cell lines (SGOCL(43))